Clinical Trial Update: Single Dose Study to Assess Efficacy, Safety and Tolerability of LAS100977 in Asthmatic Patients. [Phase 2]

View source ↗

Summary

A Phase 2 single-dose study evaluated the efficacy, safety, and tolerability of LAS100977 in asthmatic patients; the trial has completed and results were posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• LAS100977

Snippet

Sponsor: AstraZeneca | Conditions: Asthma | Phase 2 | Status: COMPLETED | Results posted: 2018-01-26